Reistone Biopharma
Reistone BioPharma is a clinical-stage biotech company focused on developing innovative medicines in autoimmune and autoinflammatory diseases. We are headquartered in Shanghai, China and have offices in Beijing, China as well in Boston and Chicago, US. Our current pipeline includes 4 small molecules in autoimmune and inflammatory diseases where significant gaps exist. The leading asset, a potent selective JAK1 inhibitor, recently completed global phase 2 trials in China, US and Europe in atopic dermatitis, ulcerative colitis and Crohn’s disease.
Currently we are looking for either partnership to develop the AD and/or UC or CD indications for phase 3 or out-license the global right excluding China market.
Currently we are looking for either partnership to develop the AD and/or UC or CD indications for phase 3 or out-license the global right excluding China market.
Paul Chen
Chief of StaffResearch Institute of Tsinghua University in Shenzhen
The Research Institute of Tsinghua University in Shenzhen (RITS) was founded in 1996. RITS strives to establish an innovation incubation system and an industrial investment platform open to both China and abroad, cultivating strategic emerging industries.
Qi Gong
Project managerShanghai Fenglin Biomedical Development Co. Ltd
Fenglin Biomedical Center (BioFM) is an innovation platform based in Xuhui Shanghai, which functions as the China soft-landing gateway for oversea bio-medical companies. It provides working spaces in downtown area in a flexible manner and helps clients increase their business value with professional services and by leveraging innovative resources including academics, hospitals, industries and venture capitals in the region. Different from the traditional accelerators and incubators, BioFM aims to be a boutique and unique service provider especially for bio-medical entrepreneurs, doctors, and scientists, while helping overseas companies and start-ups to develop their business in China quicker and better
Richard Tao
Mr / Project ManagerShanghai Jingxin Biology&Pharmaceutical Co,.LTD
Founded in 1990, Zhejiang Jingxin Pharmaceutical Co., Ltd. is a listed pharmaceutical company integrating R&D, production and sales.
The company is a national key high-tech enterprise, with a national enterprise technology center, post-doctoral research station, provincial key enterprise research institute, provincial academician expert workstation, provincial high-tech enterprise R & D center, and Shanghai Research Institute in Shanghai Zhangjiang Hi-Tech Park.
Jingxin Pharmaceutical adheres to the mission of meticulously guarding health and is committed to becoming a front runner in neurological and cardiovascular therapy areas in China.
No. 70 pharmaceutical companies in China.
The company is a national key high-tech enterprise, with a national enterprise technology center, post-doctoral research station, provincial key enterprise research institute, provincial academician expert workstation, provincial high-tech enterprise R & D center, and Shanghai Research Institute in Shanghai Zhangjiang Hi-Tech Park.
Jingxin Pharmaceutical adheres to the mission of meticulously guarding health and is committed to becoming a front runner in neurological and cardiovascular therapy areas in China.
No. 70 pharmaceutical companies in China.
Lu Tian
Project ManagerShanghai MicroPort Medical
Top medical device company in China focused on cardiovascular, surgical robotics and ten more fields.
Kaiqi Zhou
BD AssociateShanghai Pharma Holding
China top 3 pharma company in both commercialization and manufacturing sales. Dual listed on HK and Shanghai stock exchange market .
Dawei Jiang
Sr. BD ManagerShenzhen Beimei Pharmaceutical Co. Ltd.
Shenzhen Beimei Pharma is focused in the field of pediatric prescription drugs, and aims to become a new-styled pharmaceutical company integrated with R&D, in-licensing, production and sales. It takes independent R&D and the in-licensing of domestic and international pediatric products as its strategic direction. The current product pipeline covers the respiratory, anti-infection (antibacterial), neuroscience, gastroenterology and others. Beimei Pharma is committed to providing Chinese pediatric patients with convenient, accurate, excellent-taste and high-quality products.
Ivy Zhou
Head of Business DevelopmentShenzhen Pregene Biopharma Co., ltd
Pregene is a world-leading cell and gene therapy company. Pregene is committed to develop innovative gene and cell therapy technologies and create reliable products from continued innovation and R&D. And pregene can provide CDMO service.
Allen Li
BD DirectorSichuan Kelun-Biotech Biopharmaceutical Co., Ltd
Kelun-Biotech Biopharmaceutical is a subsidiary of Kelun Pharmaceutical Group established in 2016
Looking for antibody and samall molecular out-license and in-license
Chunlin Li
BD btlichl@kelun.comSimcere Pharmaceutical Group
We are rapidly transitioning to an innovation and R&D driven Pharmaceutical company, leveraging our leading manufacturing and commercial capabilities to achieve our mission of “providing today' s patients with medicines of the future“ We have been continuously recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” 1 and “Top 100 Pharmaceutical Manufacturing Enterprises of China”